Longitudinal Blood Eosinophil Profiles and Response to Anti– IL ‐5/ IL ‐ 5Rα Biologics in Severe Asthma
Clinical & Experimental Allergy · 2026-11-18
DOI: 10.1111/cea.70486 ↗At a glance
Journal article in Clinical & Experimental Allergy, published online on 2026-11-18. Written by Diana Betancor and 14 co-authors. 9 references. Funded by: Instituto de Salud Carlos III, Foundation for Iranian Studies.
Abstract (original language)
Higher historical eosinophil counts were associated with FEV 1 improvement after 1 year of anti‐IL‐5/IL‐5Rα treatment. Eosinophil variability may provide complementary information on treatment response, although its clinical value remains uncertain.
Funding
- Instituto de Salud Carlos III
- Foundation for Iranian Studies
Cite
APA
Betancor, D., Laorden, D., Rozo, M., Vecillas, L. D. L., Valverde‐Monge, M., Cañas, J. A., Romero, D., Cubillo, C. M., Sanchez, R. C., Villamanan, E., Rodriguez‐Nieto, M. J., Pozo, V. D., Sastre, J., Dominguez‐Ortega, J., & Quirce, S. (2026). Longitudinal Blood Eosinophil Profiles and Response to Anti– IL ‐5/ IL ‐ 5Rα Biologics in Severe Asthma. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70486
Vancouver
Betancor D, Laorden D, Rozo M, Vecillas LDL, Valverde‐Monge M, Cañas JA, et al. Longitudinal Blood Eosinophil Profiles and Response to Anti– IL ‐5/ IL ‐ 5Rα Biologics in Severe Asthma. Clinical & Experimental Allergy. 2026. doi:10.1111/cea.70486
BibTeX
@article{Betancor2026,
author = {Betancor, Diana and Laorden, Daniel and Rozo, Mariana and Vecillas, Leticia De las and Valverde‐Monge, Marcela and Cañas, Jose Antonio and Romero, David and Cubillo, Celia Martín and Sanchez, Raul Ceballos and Villamanan, Elena and Rodriguez‐Nieto, Maria Jesus and Pozo, Victoria del and Sastre, Joaquin and Dominguez‐Ortega, Javier and Quirce, Santiago},
title = {Longitudinal Blood Eosinophil Profiles and Response to Anti– IL ‐5/ IL ‐ 5Rα Biologics in Severe Asthma},
journal = {Clinical & Experimental Allergy},
year = {2026},
doi = {10.1111/cea.70486}
}
EUVIMED